Recent progress of functionalised graphene oxide in cancer therapy

References

• Peer D, Karp JM, Hong S, et al. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol. 2007;2:751–760.
   PubMed Web of Science ®Google Scholar
• Nezakati T, Cousins BG, Seifalian AM. Toxicology of chemically modified graphene-based materials for medical application. Arch Toxicol. 2014;88:1987–2012.
   PubMed Web of Science ®Google Scholar
• Li N, Zhao L, Qi L, et al. Polymer assembly: promising carriers as co-delivery systems for cancer therapy. Prog Polym Sci. 2016;58:1–26.
   Web of Science ®Google Scholar
• Novoselov KS, Geim AK, Morozov SV, et al. Electric field effect in atomically thin carbon films. Science. 2004;306(5696):666–669.
   PubMed Web of Science ®Google Scholar
• Lee C, Wei X, Kysar J, et al. Measurement of the elastic properties and intrinsic strength of monolayer graphene. Science. 2008;321:385–388.
   PubMed Web of Science ®Google Scholar
• Davami K, Jiang Y, Cortes J, et al. Tuning the mechanical properties of vertical graphene sheets through atomic layer deposition. Nanotechnology. 2016;27:155701.
   PubMed Web of Science ®Google Scholar
• Chen S, Chen P, Wang Y. Carbon nanotubes grown in situ on graphene nanosheets as superior anodes for Li-ion batteries. Nanoscale. 2011;3:4323–4329.
   PubMed Web of Science ®Google Scholar
• Algharagholy L, Al-Galiby Q, Marhoon H, et al. Tuning thermoelectric properties of graphene/boron nitride heterostructures. Nanotechnology. 2015;26:475401.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhao X, Jing Y, et al. Computational prediction of the electronic structure and optical properties of graphene-like β-CuN3. Phys Chem Chem Phys. 2015;17:31872–31876.
   PubMedGoogle Scholar
• Gan S, Cheng C, Zhan Y, et al. A highly efficient thermo-optic microring modulator assisted by graphene. Nanoscale. 2015;7:20249–20255.
   PubMed Web of Science ®Google Scholar
• Lu N, Liu J, Li J, et al. Tunable dual-stimuli response of a microgel composite consisting of reduced graphene oxide nanoparticles and poly(N-isopropylacrylamide) hydrogel microspheres. J Mater Chem B. 2014;2:3791–3798.
   PubMed Web of Science ®Google Scholar
• Wu C, Zhang Y, Wu X, et al. Biological applications of graphene and graphene oxide. Nano Biomed Eng. 2012;4:169–183.
   Google Scholar
• Liu J, Guo S, Han L, et al. Multiple pH-responsive graphene composites by non-covalent modification with chitosan. Talanta. 2012;101:151–156.
   PubMed Web of Science ®Google Scholar
• Byun E, Lee H. Enhanced loading efficiency and sustained release of doxorubicin from hyaluronic acid/graphene oxide composite hydrogels by a mussel-inspired catecholamine. J Nanosci Nanotechnol. 2014;14:7395–7401.
   PubMed Web of Science ®Google Scholar
• Gao W. The chemistry of graphene oxide. Berlin: Springer International Publishing; 2015.
   Google Scholar
• Chen J, Wang X, Chen T. Facile and green reduction of covalently PEGylated nanographene oxide via a ‘water-only’ route for high-efficiency photothermal therapy. Nanoscale Res Lett. 2014;9:86.
   PubMed Web of Science ®Google Scholar
• Duran N, Martinez D, Silveira C, et al. Graphene oxide: a carrier for pharmaceuticals and a scaffold for cell interactions. Curr Top Med Chem. 2015;15:309–327.
   PubMed Web of Science ®Google Scholar
• Zhi X, Fang H, Bao C, et al. The immunotoxicity of graphene oxides and the effect of PVP-coating. Biomaterials. 2013;34:5254–5261.
   PubMed Web of Science ®Google Scholar
• Muazim K, Hussain Z. Graphene oxide – a platform towards theranostics. Mater Sci Eng C Mater Biol Appl. 2017;76:1274–1288.
   PubMed Web of Science ®Google Scholar
• Rao Z, Ge H, Liu L, et al. Carboxymethyl cellulose modified graphene oxide as pH-sensitive drug delivery system. Int J Biol Macromol. 2018;107:1184–1192.
   PubMed Web of Science ®Google Scholar
• Durán N, Fávaro W. Nanopharmaceuticals and their applications in bladder cancer therapy: a mini review. J Braz Chem Soc. 2018;29:973–985.
   Web of Science ®Google Scholar
• Qin XC, Guo ZY, Liu ZM, et al. Folic acid-conjugated graphene oxide for cancer targeted chemo-photothermal therapy. J Photochem Photobiol B. 2013;120:156–162.
   PubMed Web of Science ®Google Scholar
• Hussien NA, Işıklan N, Türk M. Aptamer-functionalized magnetic graphene oxide nanocarrier for targeted drug delivery of paclitaxel. Mater Chem Phys. 2018;211:479–488.
   Web of Science ®Google Scholar
• Robinson J, Tabakman S, Liang Y, et al. Ultrasmall reduced graphene oxide with high near-infrared absorbance for photothermal therapy. J Am Chem Soc. 2011;133:6825–6831.
   PubMed Web of Science ®Google Scholar
• Lim D, Barhoumi A, Wylie R, et al. Enhanced photothermal effect of plasmonic nanoparticles coated with reduced graphene oxide. Nano Lett. 2013;13:4075–4079.
   PubMed Web of Science ®Google Scholar
• Kotchey G, Hasan S, Kapralov A, et al. A natural vanishing act: the enzyme-catalyzed degradation of carbon nanomaterials. Acc Chem Res. 2012;45:1770–1781.
   PubMed Web of Science ®Google Scholar
• Cho Y, Choi Y. Graphene oxide-photosensitizer conjugate as a redox-responsive theranostic agent. Chem Commun. 2012;48:9912–9914.
   PubMed Web of Science ®Google Scholar
• Yang K, Feng L, Shi X, et al. Nano-graphene in biomedicine: theranostic applications. Chem Soc Rev. 2013;42:530–547.
   PubMed Web of Science ®Google Scholar
• Liu Z, Robinson J, Sun X, et al. PEGylated nanographene oxide for delivery of water-insoluble cancer drugs. J Am Chem Soc. 2008;130:10876–10877.
   PubMed Web of Science ®Google Scholar
• Sun X, Liu Z, Welsher K, et al. Nano-graphene oxide for cellular imaging and drug delivery. Nano Res. 2008;1:203–212.
   PubMed Web of Science ®Google Scholar
• Du L, Wu S, Li Y, et al. Cytotoxicity of PEGylated graphene oxide on lymphoma cells. Biomed Mater Eng. 2014;24:2135–2141.
   PubMed Web of Science ®Google Scholar
• Wu HY, Lin KJ, Wang PY, et al. Polyethylene glycol-coated graphene oxide attenuates antigen-specific IgE production and enhanced antigen-induced T-cell reactivity in ovalbumin-sensitized BALB/c mice. Int J Nanomed. 2014;9:4257–4266.
   PubMed Web of Science ®Google Scholar
• Zhang L, Xia J, Zhao Q, et al. Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs. Small. 2010;6:537–544.
   PubMed Web of Science ®Google Scholar
• Ardeshirzadeh B, Anaraki NA, Irani M, et al. Controlled release of doxorubicin from electrospun PEO/chitosan/graphene oxide nanocomposite nanofibrous scaffolds. Mater Sci Eng C Mater. 2015;48:384–390.
   PubMed Web of Science ®Google Scholar
• Cheng HK, Sahoo NG, Tan YP, et al. Poly(vinyl alcohol) nanocomposites filled with poly(vinyl alcohol)-grafted graphene oxide. ACS Appl Mater Interfaces. 2012;4:2387–2394.
   PubMed Web of Science ®Google Scholar
• Sharma SK, Prakash J, Pujari PK. Effects of the molecular level dispersion of graphene oxide on the free volume characteristics of poly (vinyl alcohol) and its impact on the thermal and mechanical properties of their nanocomposites. Phys Chem Chem Phys. 2015;17:29201–29209.
   PubMed Web of Science ®Google Scholar
• Tsoufis T, Katsaros F, Sideratou Z, et al. Intercalation study of low-molecular-weight hyperbranched polyethyleneimine into graphite oxide. Chem Eur J. 2014;20:8129–8137.
   PubMed Web of Science ®Google Scholar
• Yan L, Chang YN, Zhao L, et al. The use of polyethylenimine-modified graphene oxide as a nanocarrier for transferring hydrophobic nanocrystals into water to produce water-dispersible hybrids for use in drug delivery. Carbon. 2013;57:120–129.
   Web of Science ®Google Scholar
• Alibolandi M, Mohammadi M, Taghdisi SM, et al. Fabrication of aptamer decorated dextran coated nano-graphene oxide for targeted drug delivery. Carbohydr Polym. 2017;155:218–229.
   PubMed Web of Science ®Google Scholar
• Mu L, Gao Y, Hu X. l-Cysteine: a biocompatible, breathable and beneficial coating for graphene oxide. Biomaterials. 2015;52:301–311.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Wu Z, Li N, et al. Advanced review of graphene-based nanomaterials in drug delivery systems: synthesis, modification, toxicity and application. Mater Sci Eng C Mater. 2017;77:1363–1375.
   PubMed Web of Science ®Google Scholar
• Zhang B, Wang Y, Liu J, et al. Recent developments of phototherapy based on graphene family nanomaterials. Curr Med Chem. 2016;24:268–291.
   Web of Science ®Google Scholar
• Stankovich S, Piner RD, Nguyen ST, et al. Synthesis and exfoliation of isocyanate-treated graphene oxide nanoplatelets. Carbon. 2006;44:3342–3347.
   Web of Science ®Google Scholar
• Cheng J, Qiu Y, Huang R, et al. Biodiesel production from wet microalgae by using graphene oxide as solid acid catalyst. Bioresour Technol. 2016;221:344–349.
   PubMed Web of Science ®Google Scholar
• Li Y, Feng L, Shi X, et al. Surface coating-dependent cytotoxicity and degradation of graphene derivatives: towards the design of non-toxic, degradable nano-graphene. Small. 2014;10:1544–1554.
   PubMed Web of Science ®Google Scholar
• Wen H, Dong C, Dong H, et al. Engineered redox-responsive PEG detachment mechanism in PEGylated nano-graphene oxide for intracellular drug delivery. Small. 2012;8:760–769.
   PubMed Web of Science ®Google Scholar
• Stankovich S, Piner RD, Chen X, et al. Stable aqueous dispersions of graphitic nanoplatelets via the reduction of exfoliated graphite oxide in the presence of poly (sodium 4-styrenesulfonate). J Mater Chem. 2005;16:155–158.
   Web of Science ®Google Scholar
• Pandele AM, Andronescu C, Vasile E, et al. Non-covalent functionalization of GO for improved mechanical performances of pectin composite films. Compos A Appl Sci Manuf. 2017;103:188–195.
   Web of Science ®Google Scholar
• Akter R, Jeong B, Choi JS, et al. Ultrasensitive nanoimmunosensor by coupling non-covalent functionalized graphene oxide platform and numerous ferritin labels on carbon nanotubes. Biosens Bioelectron. 2016;80:123–130.
   PubMed Web of Science ®Google Scholar
• Chauhan G, Chopra V, Tyagi A, et al. “Gold nanoparticles composite-folic acid conjugated graphene oxide nanohybrids” for targeted chemo-thermal cancer ablation: in vitro screening and in vivo studies. Eur J Pharm Sci. 2016;96:351–361.
   PubMed Web of Science ®Google Scholar
• Hwang DW, Kim HY, Li F, et al. In vivo visualization of endogenous miR-21 using hyaluronic acid-coated graphene oxide for targeted cancer therapy. Biomaterials. 2017;121:144–154.
   PubMed Web of Science ®Google Scholar
• Yang H, Bremner DH, Lei T, et al. Carboxymethyl chitosan-mediated synthesis of hyaluronic acid-targeted graphene oxide for cancer drug delivery. Carbohydr Polym. 2016;135:72–78.
   PubMed Web of Science ®Google Scholar
• Song E, Han W, Li C, et al. Hyaluronic acid-decorated graphene oxide nanohybrids as nanocarriers for targeted and pH-responsive anticancer drug delivery. ACS Appl Mater Interfaces. 2014;6:11882–11890.
   PubMed Web of Science ®Google Scholar
• Ma N, Liu J, He W, et al. Folic acid-grafted bovine serum albumin decorated graphene oxide: an efficient drug carrier for targeted cancer therapy. J Colloid Interface Sci. 2017;490:598–607.
   PubMed Web of Science ®Google Scholar
• Ma J, Pan J, Yue J, et al. High performance of poly(dopamine)-functionalized graphene oxide/poly(vinyl alcohol) nanocomposites. Appl Surf Sci. 2017;427:428–436.
   Web of Science ®Google Scholar
• Angelopoulou A, Voulgari E, Diamanti EK, et al. Graphene oxide stabilized by PLA-PEG copolymers for the controlled delivery of paclitaxel. Eur J Pharm Biopharm. 2015;93:18–26.
   PubMed Web of Science ®Google Scholar
• Wang K, Jing R, Song H, et al. Biocompatibility of graphene oxide. Nanoscale Res Lett. 2011;6:8.
   PubMed Web of Science ®Google Scholar
• Chng EL, Pumera M. The toxicity of graphene oxides: dependence on the oxidative methods used. Chemistry. 2013;19:8227–8235.
   PubMed Web of Science ®Google Scholar
• Vallabani NVS, Mittal S, Shukla R, et al. Toxicity of graphene in normal human lung cells (BEAS-2B). J Biomed Nanotechnol. 2011;7:106–107.
   PubMed Web of Science ®Google Scholar
• Durán M, Durán N, Fávaro WJ. In vivo nanotoxicological profile of graphene oxide. J Phys: Conf Ser. 2017;838:012026.
   Google Scholar
• Kan W, Jing R, Hua S, et al. Biocompatibility of graphene oxide. Nanoscale Res Lett. 2011;6:1–8.
   Web of Science ®Google Scholar
• Elyamany NA, Mohamed FF, Salaheldin TA, et al. Graphene oxide nanosheets induced genotoxicity and pulmonary injury in mice. Exp Toxicol Pathol. 2017;6:383–392.
   Google Scholar
• Bengtson S, Knudsen KB, Kyjovska ZO, et al. Differences in inflammation and acute phase response but similar genotoxicity in mice following pulmonary exposure to graphene oxide and reduced graphene oxide. PLoS One. 2017;12:0178355.
   PubMed Web of Science ®Google Scholar
• Duch MC, Budinger GR, Liang YT, et al. Minimizing oxidation and stable nanoscale dispersion improves the biocompatibility of graphene in the lung. Nano Lett. 2011;11:5201–5207.
   PubMed Web of Science ®Google Scholar
• Kiew SF, Kiew LV, Lee HB, et al. Assessing biocompatibility of graphene oxide-based nanocarriers: a review. J Control Release. 2016;226:217–228.
   PubMed Web of Science ®Google Scholar
• Cheng C, Nie S, Li S, et al. Biopolymer functionalized reduced graphene oxide with enhanced biocompatibility via mussel inspired coatings/anchors. J Mater Chem B. 2013;1:265–275.
   PubMed Web of Science ®Google Scholar
• Zhang X, Yin J, Peng C, et al. Distribution and biocompatibility studies of graphene oxide in mice after intravenous administration. Carbon. 2011;49:986–995.
   Web of Science ®Google Scholar
• Guo X, Mei N. Assessment of the toxic potential of graphene family nanomaterials. J Food Drug Anal. 2014;22:105–115.
   PubMed Web of Science ®Google Scholar
• Chatterjee N, Yang JS, Park K, et al. Screening of toxic potential of graphene family nanomaterials using in vitro and alternative in vivo toxicity testing systems. Environ Health Toxicol. 2015;30:e2015007.
   PubMedGoogle Scholar
• Zhang Y, Nayak TR, Hong H, et al. Graphene: a versatile nanoplatform for biomedical applications. Nanoscale. 2012;4:3833–3842.
   PubMed Web of Science ®Google Scholar
• Zhou T, Zhou X, Xing D. Controlled release of doxorubicin from graphene oxide based charge-reversal nanocarrier. Biomaterials. 2014;35:4185–4194.
   PubMed Web of Science ®Google Scholar
• Yao L, Lei T, Bligh SWA, et al. Targeted delivery and controlled release of doxorubicin into cancer cells using a multifunctional graphene oxide. Mater Sci Eng C Mater. 2016;59:652–660.
   PubMed Web of Science ®Google Scholar
• Zhang C, Liu Z, Zheng Y, et al. Glycyrrhetinic acid functionalized graphene oxide for mitochondria targeting and cancer treatment in vivo. Small. 2017;14:1703306.
   Web of Science ®Google Scholar
• Yang K, Feng L, Liu Z. Stimuli responsive drug delivery systems based on nano-graphene for cancer therapy. Adv Drug Deliv Rev. 2016;105:228–241.
   PubMed Web of Science ®Google Scholar
• Zhang B, Yan Y, Shen Q, et al. A colon targeted drug delivery system based on alginate modificated graphene oxide for colorectal liver metastasis. Mater Sci Eng C Mater. 2017;79:185–190.
   PubMed Web of Science ®Google Scholar
• Song MM, Xu HL, Liang JX, et al. Lactoferrin modified graphene oxide iron oxide nanocomposite for glioma-targeted drug delivery. Mater Sci Eng C Mater. 2017;77:904–911.
   PubMed Web of Science ®Google Scholar
• Zhu J, Xu M, Gao M, et al. Graphene oxide-induced perturbation to plasma membrane and cytoskeletal meshwork sensitize cancer cells to chemotherapeutic agents. ACS Nano. 2017;11:2637–2651.
   PubMed Web of Science ®Google Scholar
• Zhang J, Feng L, Tan X, et al. Dual-polymer-functionalized nanoscale graphene oxide as a highly effective gene transfection agent for insect cells with cell-type-dependent cellular uptake mechanisms. Part Part Syst Charact. 2013;30:794–803.
   Web of Science ®Google Scholar
• Huang YP, Hung CM, Hsu YC, et al. Suppression of breast cancer cell migration by small interfering RNA delivered by polyethylenimine-functionalized graphene oxide. Nanoscale Res Lett. 2016;11:247.
   PubMed Web of Science ®Google Scholar
• Cao X, Feng F, Wang Y, et al. Folic acid-conjugated graphene oxide as a transporter of chemotherapeutic drug and siRNA for reversal of cancer drug resistance. J Nanopart Res. 2013;15:1965.
   Web of Science ®Google Scholar
• Cao X, Zheng S, Zhang S, et al. Functionalized graphene oxide with hepatocyte targeting as anti-tumor drug and gene intracellular transporters. J Nanosci Nanotechnol. 2015;15:2052–2059.
   PubMed Web of Science ®Google Scholar
• Sahu A, Choi WI, Lee JH, et al. Graphene oxide mediated delivery of methylene blue for combined photodynamic and photothermal therapy. Biomaterials. 2013;34:6239–6248.
   PubMed Web of Science ®Google Scholar
• Liu G, Qin H, Amano T, et al. Direct fabrication of the graphene-based composite for cancer phototherapy through graphite exfoliation with a photosensitizer. ACS Appl Mater Interfaces. 2015;7:23402–23406.
   PubMed Web of Science ®Google Scholar
• Li M, Yang X, Ren J, et al. Using graphene oxide high near-infrared absorbance for photothermal treatment of Alzheimer's disease. Adv Mater. 2012;24:1722–1728.
   PubMed Web of Science ®Google Scholar
• Bai YY, Zheng S, Zhang L, et al. Non-invasively evaluating therapeutic response of nanorod-mediated photothermal therapy on tumor angiogenesis. J Biomed Nanotechnol. 2014;10:3351–3360.
   PubMed Web of Science ®Google Scholar
• Van dZJ. Heating the patient: a promising approach? Ann Oncol. 2002;13:1173–1184.
   PubMed Web of Science ®Google Scholar
• Zhang R, Su S, Hu K, et al. Smart micelle@polydopamine core-shell nanoparticles for highly effective chemo-photothermal combination therapy. Nanoscale. 2015;7:19722–19731.
   PubMed Web of Science ®Google Scholar
• Fang J, Chen YC. Nanomaterials for photohyperthermia: a review. Curr Pharm Des. 2013;19:6622–6634.
   PubMed Web of Science ®Google Scholar
• Dreaden EC, Mackey MA, Huang X, et al. Beating cancer in multiple ways using nanogold. Chem Soc Rev. 2011;40:3391–3404.
   PubMed Web of Science ®Google Scholar
• Choi J, Yang J, Jang E, et al. Gold nanostructures as photothermal therapy agent for cancer. Anticancer Agents Med Chem. 2011;11:953–964.
   PubMed Web of Science ®Google Scholar
• Yang L, Tseng YT, Suo G, et al. Photothermal therapeutic response of cancer cells to aptamer-gold nanoparticle-hybridized graphene oxide under NIR illumination. ACS Appl Mater Interfaces. 2015;7:5097–5106.
   PubMed Web of Science ®Google Scholar
• Yan L, Qiu L. Indocyanine green targeted micelles with improved stability for near-infrared image-guided photothermal tumor therapy. Nanomedicine (UK). 2015;10:361–373.
   PubMed Web of Science ®Google Scholar
• Fernandez Cabada T, Sanchez Lopez de Pablo C, Martinez Serrano A, et al. Induction of cell death in a glioblastoma line by hyperthermic therapy based on gold nanorods. Int J Nanomed. 2012;7:1511–1523.
   PubMed Web of Science ®Google Scholar
• Vila M, Matesanz MC, Gonçalves G, et al. Triggering cell death by nanographene oxide mediated hyperthermia. Nanotechnology. 2014;25:035101.
   PubMed Web of Science ®Google Scholar
• Lepock JR. Cellular effects of hyperthermia: relevance to the minimum dose for thermal damage. Int J Hyperthermia. 2003;19:252–266.
   PubMed Web of Science ®Google Scholar
• Feng L, Yang X, Shi X, et al. Polyethylene glycol and polyethylenimine dual-functionalized nano-graphene oxide for photothermally enhanced gene delivery. Small. 2013;9:1989–1997.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Dai T, Wang M, et al. Potentiation of antimicrobial photodynamic inactivation mediated by a cationic fullerene by added iodide: in vitro and in vivo studies. Nanomedicine (UK). 2015;10:603–614.
   PubMed Web of Science ®Google Scholar
• Kim YK, Na HK, Kim S, et al. One-pot synthesis of multifunctional Au@graphene oxide nanocolloid core@shell nanoparticles for Raman bioimaging, photothermal, and photodynamic therapy. Small. 2015;11:2527–2535.
   PubMed Web of Science ®Google Scholar
• Yan X, Hu H, Lin J, et al. Optical and photoacoustic dual-modality imaging guided synergistic photodynamic/photothermal therapies. Nanoscale. 2015;7:2520–2526.
   PubMed Web of Science ®Google Scholar
• Dolmans DEJGJ, Dai F, Jain RK. Photodynamic therapy for cancer. Nat Rev Cancer. 2003;3:380–387.
   PubMed Web of Science ®Google Scholar
• Acedo P, Zawackapankau J. P53 family members – important messengers in cell death signaling in photodynamic therapy of cancer? Photochem Photobiol Sci. 2015;14:1390–1396.
   PubMed Web of Science ®Google Scholar
• Castano AP, Demidova TN, Hamblin MR. Mechanisms in photodynamic therapy: part three-photosensitizer pharmacokinetics, biodistribution, tumor localization and modes of tumor destruction. Photodiagn Photodyn. 2005;2:91–106.
   PubMed Web of Science ®Google Scholar
• Kochneva EV, Filonenko EV, Vakulovskaya EG, et al. Photosensitizer Radachlorin®: skin cancer PDT phase II clinical trials. Photodiagn Photodyn. 2010;7:258–267.
   PubMed Web of Science ®Google Scholar
• Yavari N, Andersson-Engels S, Segersten U, et al. An overview on preclinical and clinical experiences with photodynamic therapy for bladder cancer. Can J Urol. 2011;18:5778–5786.
   PubMed Web of Science ®Google Scholar
• Simone CB, Cengel KA. Photodynamic therapy for lung cancer and malignant pleural mesothelioma. Semin Oncol. 2014;41:820–830.
   PubMed Web of Science ®Google Scholar
• Cao W, Zeng X, Liu G, et al. Porphine functionalized nanoparticles of star-shaped poly(ε-caprolactone)-b-d-α-tocopheryl polyethylene glycol 1000 succinate biodegradable copolymer for chemophotodynamic therapy on cervical cancer. Acta Biomater. 2015;26:145–158.
   PubMed Web of Science ®Google Scholar
• Li PX, Mu JH, Xiao HL, et al. Antitumor effect of photodynamic therapy with a novel targeted photosensitizer on cervical carcinoma. Oncol Rep. 2015;33:125–132.
   PubMed Web of Science ®Google Scholar
• Xu J, Fang Z, Hao W, et al. Dual-targeting nanosystem for enhancing photodynamic therapy efficiency. ACS Appl Mater Interfaces. 2015;7:9287–9296.
   PubMed Web of Science ®Google Scholar
• Mirzaei H, Djavid GE, Hadizadeh M, et al. The efficacy of Radachlorin-mediated photodynamic therapy in human hepatocellular carcinoma cells. J Photochem Photobiol B. 2015;142:86–91.
   PubMed Web of Science ®Google Scholar
• Li Y, Dong H, Li Y, et al. Graphene-based nanovehicles for photodynamic medical therapy. Int J Nanomedicine. 2015;10:2451–2459.
   PubMed Web of Science ®Google Scholar
• Kılıç SA, Selmanoğlu G, Akay MT. Alterations in dysadherin expression and F-actin reorganization: a possible mechanism of hypericin-mediated photodynamic therapy in colon adenocarcinoma cells. Cytotechnology. 2015;67:311–330.
   PubMed Web of Science ®Google Scholar
• Bastien E, Schneider R, Hackbarth S, et al. PAMAM G4.5-chlorin e6 dendrimeric nanoparticles for enhanced photodynamic effects. Photochem Photobiol Sci. 2015;14:2203–2212.
   PubMed Web of Science ®Google Scholar
• Rapozzi V, Della PE, Bonavida B. Dual roles of nitric oxide in the regulation of tumor cell response and resistance to photodynamic therapy. Redox Biol. 2015;6:311–317.
   PubMed Web of Science ®Google Scholar
• Lucky SS, Soo KC, Zhang Y. Nanoparticles in photodynamic therapy. Chem Rev. 2015;115:1990–2042.
   PubMed Web of Science ®Google Scholar
• Zhu L, Torchilin VP. Stimulus-responsive nanopreparations for tumor targeting. Integr Biol (UK). 2013;5:96–107.
   PubMed Web of Science ®Google Scholar
• Jhaveri A, Deshpande P, Torchilin V. Stimuli-sensitive nanopreparations for combination cancer therapy. J Control Release. 2014;190:352–370.
   PubMed Web of Science ®Google Scholar
• Lin L, Xiong L, Wen Y, et al. Active targeting of nano-photosensitizer delivery systems for photodynamic therapy of cancer stem cells. J Biomed Nanotechnol. 2015;11:531–554.
   PubMed Web of Science ®Google Scholar
• Gao L, Fei J, Zhao J, et al. Hypocrellin-loaded gold nanocages with high two-photon efficiency for photothermal/photodynamic cancer therapy in vitro. ACS Nano. 2012;6:8030–8040.
   PubMed Web of Science ®Google Scholar
• Ding Y, Zhou L, Chen X, et al. Mutual sensitization mechanism and self-degradation property of drug delivery system for in vitro photodynamic therapy. Int J Pharm. 2016;498:335–346.
   PubMedGoogle Scholar
• Du D, Wang K, Wen Y, et al. Photodynamic graphene quantum dot: reduction condition regulated photo-activity and size dependent efficacy. ACS Appl Mater Interfaces. 2016;8:3287–3294.
   PubMed Web of Science ®Google Scholar
• Guo M, Mao H, Li Y, et al. Dual imaging-guided photothermal/photodynamic therapy using micelles. Biomaterials. 2014;35:4656–4666.
   PubMed Web of Science ®Google Scholar
• Liu T, Wang C, Cui W, et al. Combined photothermal and photodynamic therapy delivered by PEGylated MoS2 nanosheets. Nanoscale. 2014;6:11219–11225.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang H, Liu D, et al. Graphene oxide covalently grafted upconversion nanoparticles for combined NIR mediated imaging and photothermal/photodynamic cancer therapy. Biomaterials. 2013;34:7715–7724.
   PubMed Web of Science ®Google Scholar
• Zhang D, Wu M, Zeng Y, et al. Chlorin e6 conjugated poly(dopamine) nanospheres as PDT/PTT dual-modal therapeutic agents for enhanced cancer therapy. ACS Appl Mater Interfaces. 2015;7:8176–8187.
   PubMed Web of Science ®Google Scholar
• Li Q, Hong L, Li H, et al. Graphene oxide-fullerene C60 (GO-C60) hybrid for photodynamic and photothermal therapy triggered by near-infrared light. Biosens Bioelectron. 2016;89:477–482.
   PubMed Web of Science ®Google Scholar
• Dos Santos MSC, Gouvea AL, de Moura LD, et al. Nanographene oxide-methylene blue as phototherapies platform for breast tumor ablation and metastasis prevention in a syngeneic orthotopic murine model. J Nanobiotechnol. 2018;16:9.
   PubMed Web of Science ®Google Scholar
• Bao T, Yin W, Zheng X, et al. One-pot synthesis of PEGylated plasmonic MoO(3-x) hollow nanospheres for photoacoustic imaging guided chemo-photothermal combinational therapy of cancer. Biomaterials. 2016;76:11–24.
   PubMed Web of Science ®Google Scholar
• Tao Y, Ju E, Liu Z, et al. Engineered, self-assembled near-infrared photothermal agents for combined tumor immunotherapy and chemo-photothermal therapy. Biomaterials. 2014;35:6646–6656.
   PubMed Web of Science ®Google Scholar
• Ren F, Bhana S, Norman DD, et al. Gold nanorods carrying paclitaxel for photothermal-chemotherapy of cancer. Bioconjug Chem. 2013;24:376–386.
   PubMed Web of Science ®Google Scholar
• Wan H, Zhang Y, Liu Z, et al. Facile fabrication of a near-infrared responsive nanocarrier for spatiotemporally controlled chemo-photothermal synergistic cancer therapy. Nanoscale. 2014;6:8743–8753.
   PubMed Web of Science ®Google Scholar
• Bai J, Liu Y, Jiang X. Multifunctional PEG-GO/CuS nanocomposites for near-infrared chemo-photothermal therapy. Biomaterials. 2014;35:5805–5813.
   PubMed Web of Science ®Google Scholar
• Yang HW, Lu YJ, Lin KJ, et al. EGRF conjugated PEGylated nanographene oxide for targeted chemotherapy and photothermal therapy. Biomaterials. 2013;34:7204–7214.
   PubMed Web of Science ®Google Scholar
• Xiong H, Guo Z, Zhang W, et al. Redox-responsive biodegradable PEGylated nanographene oxide for efficiently chemo-photothermal therapy: a comparative study with non-biodegradable PEGylated nanographene oxide. J Photochem Photobiol B. 2014;138:191–201.
   PubMed Web of Science ®Google Scholar
• Ren TB, Xia WJ, Dong HQ, et al. Sheddable micelles based on disulfide-linked hybrid PEG-polypeptide copolymer for intracellular drug delivery. Polymer. 2011;52:3580–3586.
   Web of Science ®Google Scholar
• Zhang W, Guo Z, Huang D, et al. Synergistic effect of chemo-photothermal therapy using PEGylated graphene oxide. Biomaterials. 2011;32:8555–8561.
   PubMed Web of Science ®Google Scholar
• Xu Z, Wu S, Huang G, et al. Aptamer-modified CuS nanocrystals/graphene oxide composites for controlled release of glucosamine and chemo-photothermal therapy of tumor cells. Mater Lett. 2017;195:131–135.
   Web of Science ®Google Scholar
• Li J, Lyv Z, Li Y, et al. A theranostic prodrug delivery system based on Pt(IV) conjugated nano-graphene oxide with synergistic effect to enhance the therapeutic efficacy of Pt drug. Biomaterials. 2015;51:12–21.
   PubMed Web of Science ®Google Scholar
• Khan MS, Pandey S, Bhaisare ML, et al. Graphene oxide@gold nanorods for chemo-photothermal treatment and controlled release of doxorubicin in mice tumor. Colloid Surf B. 2017;160:543–552.
   PubMed Web of Science ®Google Scholar
• Tian Z, Yao X, Zhu Y. Simple synthesis of multifunctional zeolitic imidazolate frameworks-8/graphene oxide nanocrystals with controlled drug release and photothermal effect. Micropor Mesopor Mater. 2017;237:160–167.
   Web of Science ®Google Scholar
• Du J, Liu J, Gong P, et al. Construction of a novel fluorinated graphene-based magnetic nanocomposite and its application in cancer photo-chemotherapy. Mater Lett. 2017;2:103–121.
   Google Scholar
• Shi J, Wang L, Zhang J, et al. A tumor-targeting near-infrared laser-triggered drug delivery system based on GO@Ag nanoparticles for chemo-photothermal therapy and X-ray imaging. Biomaterials. 2014;35:5847–5861.
   PubMed Web of Science ®Google Scholar
• Zare M, Maryam Z, Milad B, et al. Aberrant miRNA promoter methylation and EMT-involving miRNAs in breast cancer metastasis: diagnosis and therapeutic implications. J Cell Physiol. 2018;233:3729–3744.
   PubMed Web of Science ®Google Scholar
• Mei Y, Liu H, Sun X, et al. Plasma fibrinogen level may be a possible marker for the clinical response and prognosis of patients with breast cancer receiving neoadjuvant chemotherapy. Tumour Biol. 2017;39:700002.
   Google Scholar
• Zhang X. The study of the effect on the treatment for the local advanced breast cancer by neoadjuvant chemotherapy. Qinghai Med J. 2017;26:223–245.
   Google Scholar
• Wang F, Sun Q, Feng B, et al. Polydopamine-functionalized graphene oxide loaded with gold nanostars and doxorubicin for combined photothermal and chemotherapy of metastatic breast cancer. Adv Healthcare Mater. 2016;5:2227–2236.
   Web of Science ®Google Scholar
• Trindade GS, Farias SL, Rumjanek VM, et al. Methylene blue reverts multidrug resistance: sensitivity of multidrug resistant cells to this dye and its photodynamic action. Cancer Lett. 2000;151:161–167.
   PubMed Web of Science ®Google Scholar
• Khdair A, Handa HG, Panyam J. Nanoparticle-mediated combination chemotherapy and photodynamic therapy overcomes tumor drug resistance in vitro. Eur J Pharm Biopharm. 2009;71:214–222.
   PubMed Web of Science ®Google Scholar
• Chen R, Zhang J, Wang Y, et al. Graphitic carbon nitride nanosheet@metal-organic framework core-shell nanoparticles for photo-chemo combination therapy. Nanoscale. 2015;7:17299–17305.
   PubMed Web of Science ®Google Scholar
• Xiaofei C, Xuemei Y, Li C, et al. Acid-sensitive nanogels for synergistic chemo-photodynamic therapy. Macromol Biosci. 2015;15:1563–1570.
   PubMed Web of Science ®Google Scholar
• Diez B, Ernst G, Teijo MJ, et al. Combined chemotherapy and ALA-based photodynamic therapy in leukemic murine cells. Leuk Res. 2012;36:1179–1184.
   PubMed Web of Science ®Google Scholar
• Lin Z, Lin Z, Shaohua W, et al. Combination of chemotherapy and photodynamic therapy using graphene oxide as drug delivery system. J Photochem Photobiol B. 2014;135:7–16.
   PubMed Web of Science ®Google Scholar
• Miao W, Shim G, Lee S, et al. Safety and tumor tissue accumulation of pegylated graphene oxide nanosheets for co-delivery of anticancer drug and photosensitizer. Biomaterials. 2013;34:3402–3410.
   PubMed Web of Science ®Google Scholar
• Feng L, Wu L, Qu X. New horizons for diagnostics and therapeutic applications of graphene and graphene oxide. Adv Mater. 2013;25:168–186.
   PubMed Web of Science ®Google Scholar
• Li JL, Tang B, Yuan B, et al. A review of optical imaging and therapy using nanosized graphene and graphene oxide. Biomaterials. 2013;34:9519–9534.
   PubMed Web of Science ®Google Scholar
• Liu F, He X, Lei Z, et al. Facile preparation of doxorubicin-loaded upconversion@polydopamine nanoplatforms for simultaneous in vivo multimodality imaging and chemophotothermal synergistic therapy. Adv Healthcare Mater. 2015;4:559–568.
   Web of Science ®Google Scholar
• Nurunnabi M, Khatun Z, Reeck GR, et al. Photoluminescent graphene nanoparticles for cancer phototherapy and imaging. ACS Appl Mater Interfaces. 2014;6:12413–12421.
   PubMed Web of Science ®Google Scholar
• Wang Y, Chen JT, Yan XP. Fabrication of transferrin functionalized gold nanoclusters/graphene oxide nanocomposite for turn-on near-infrared fluorescent bioimaging of cancer cells and small animals. Anal Chem. 2013;85:2529–2535.
   PubMed Web of Science ®Google Scholar
• Yang K, Hu L, Ma X, et al. Multimodal imaging guided photothermal therapy using functionalized graphene nanosheets anchored with magnetic nanoparticles. Adv Mater. 2012;24:1868–1872.
   PubMed Web of Science ®Google Scholar
• Chen W, Yi P, Zhang Y, et al. Composites of aminodextran-coated Fe3O4 nanoparticles and graphene oxide for cellular magnetic resonance imaging. ACS Appl Mater Interfaces. 2011;3:4085–4091.
   PubMed Web of Science ®Google Scholar
• Meng J, Chen X, Tian Y, et al. Nanoscale metal-organic frameworks decorated with graphene oxide for magnetic resonance imaging guided photothermal therapy. Chem Eur J. 2017;23:17521–17530.
   PubMed Web of Science ®Google Scholar
• Usman MS, Hussein MZ, Fakurazi S, et al. Gadolinium-based layered double hydroxide and graphene oxide nano-carriers for magnetic resonance imaging and drug delivery. Chem Cent J. 2017;11:47.
   PubMed Web of Science ®Google Scholar
• Li Z, Tian L, Liu J, et al. Graphene oxide/Ag nanoparticles cooperated with simvastatin as a high sensitive X-ray computed tomography imaging agent for diagnosis of renal dysfunctions. Adv Healthcare Mater. 2017;6:1700413.
   Web of Science ®Google Scholar
• Jin Y, Wang J, Ke H, et al. Graphene oxide modified PLA microcapsules containing gold nanoparticles for ultrasonic/CT bimodal imaging guided photothermal tumor therapy. Biomaterials. 2013;34:4794–4802.
   PubMed Web of Science ®Google Scholar
• Delogu L, Vidili G, Venturelli E, et al. Functionalized multiwalled carbon nanotubes as ultrasound contrast agents. Proc Natl Acad Sci USA. 2012;109:16612–16617.
   PubMed Web of Science ®Google Scholar
• Jasim DA, Boutin H, Fairclough M, et al. Thickness of functionalized graphene oxide sheets plays critical role in tissue accumulation and urinary excretion: a pilot PET/CT study. Mater Today. 2016;4:24–30.
   Web of Science ®Google Scholar
• Fazaeli Y, Akhavan O, Rahighi R, et al. In vivo, SPECT imaging of tumors by 198,199Au-labeled graphene oxide nanostructures. Mater Sci Eng C Mater. 2014;45:196–204.
   PubMed Web of Science ®Google Scholar
• Lin J, Chen X, Huang P. Graphene-based nanomaterials for bioimaging. Adv Drug Deliv Rev. 2016;105:242–254.
   PubMed Web of Science ®Google Scholar
• Fu L, Ke HT. Nanomaterials incorporated ultrasound contrast agents for cancer theranostics. Cancer Biol Med. 2016;13:313–324.
   PubMed Web of Science ®Google Scholar
• Chen J, Liu C, Zeng G, et al. Indocyanine green loaded reduced graphene oxide for in vivo photoacoustic/fluorescence dual-modality tumor imaging. Nanoscale Res Lett. 2016;11:85.
   PubMed Web of Science ®Google Scholar
• Rong P, Yang K, Srivastan A, et al. Photosensitizer loaded nano-graphene for multimodality imaging guided tumor photodynamic therapy. Theranostics. 2014;4:229–239.
   PubMed Web of Science ®Google Scholar
• Cao T, You P, Zhou X, et al. Visualization of size-dependent tumour retention of PEGylated nanographene oxide via SPECT imaging. J Mater Chem B. 2016;4:6446–6453.
   Web of Science ®Google Scholar
• Cornelissen B, Able S, Kersemans V, et al. Nanographene oxide-based radioimmunoconstructs for in vivo targeting and SPECT imaging of HER2-positive tumors. Biomaterials. 2013;34:1146–1154.
   PubMed Web of Science ®Google Scholar
• Shi S, Yang K, Hong H, et al. Tumor vasculature targeting and imaging in living mice with reduced graphene oxide. Biomaterials. 2013;34:3002–3009.
   PubMed Web of Science ®Google Scholar
• Cao T, Zhou X, Zheng Y, et al. Chelator-free conjugation of (99m)Tc and Gd(3+) to PEGylated nanographene oxide for dual-modality SPECT/MR imaging of lymph nodes. ACS Appl Mater Interfaces. 2017;9:42612–42621.
   PubMed Web of Science ®Google Scholar
• Shen AJ, Li DL, Cai XJ, et al. Multifunctional nanocomposite based on graphene oxide for in vitro hepatocarcinoma diagnosis and treatment. J Biomed Mater Res A. 2012;100:2499–2506.
   PubMed Web of Science ®Google Scholar
• Pei H, Li J, Lv M, et al. A graphene-based sensor array for high-precision and adaptive target identification with ensemble aptamers. J Am Chem Soc. 2012;134:13843–13849.
   PubMed Web of Science ®Google Scholar
• Zhang H, Wu H, Wang J, et al. Graphene oxide-BaGdF5 nanocomposites for multi-modal imaging and photothermal therapy. Biomaterials. 2015;42:66–77.
   PubMed Web of Science ®Google Scholar
• Shi X, Gong H, Li Y, et al. Graphene-based magnetic plasmonic nanocomposite for dual bioimaging and photothermal therapy. Biomaterials. 2013;34:4786–4793.
   PubMed Web of Science ®Google Scholar
• Lovell JF, Liu TW, Chen J, et al. Activatable photosensitizers for imaging and therapy. Chem Rev. 2010;110:2839–2857.
   PubMed Web of Science ®Google Scholar
• Yan X, Niu G, Lin J, et al. Enhanced fluorescence imaging guided photodynamic therapy of sinoporphyrin sodium loaded graphene oxide. Biomaterials. 2015;42:94–102.
   PubMed Web of Science ®Google Scholar
• Viraka Nellore BP, Pramanik A, Chavva SR, et al. Aptamer-conjugated theranostic hybrid graphene oxide with highly selective biosensing and combined therapy capability. Faraday Discuss. 2015;175:257–271.
   Web of Science ®Google Scholar
• Kalluru P, Vankayala R, Chiang CS, et al. Nano-graphene oxide-mediated in vivo fluorescence imaging and bimodal photodynamic and photothermal destruction of tumors. Biomaterials. 2016;95:1–10.
   PubMed Web of Science ®Google Scholar
• Cho Y, Kim H, Choi Y. A graphene oxide-photosensitizer complex as an enzyme-activatable theranostic agent. Chem Commun. 2013;49:1202–1204.
   PubMed Web of Science ®Google Scholar